Jayson Bedford
Stock Analyst at Raymond James
(3.86)
# 667
Out of 5,055 analysts
323
Total ratings
55.56%
Success rate
7.32%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $23.57 | +14.55% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $546.71 | +10.30% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $12.88 | +47.52% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $130.03 | +12.28% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $199.58 | +4.72% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $88.64 | +27.48% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $134.52 | +33.81% | 21 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $85.79 | +18.89% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $58.49 | +74.39% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $101.76 | +21.86% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $328.02 | +9.75% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $204 → $185 | $147.03 | +25.82% | 7 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $190.98 | +41.38% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $11.91 | -16.04% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $103.86 | +160.93% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $15.18 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $18.34 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $84.74 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $17.77 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $96.28 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $5.90 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $74.14 | +16.00% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.54 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.73 | - | 3 | Jan 2, 2018 |
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $23.57
Upside: +14.55%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $546.71
Upside: +10.30%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $12.88
Upside: +47.52%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $130.03
Upside: +12.28%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $199.58
Upside: +4.72%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $88.64
Upside: +27.48%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $134.52
Upside: +33.81%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $85.79
Upside: +18.89%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $58.49
Upside: +74.39%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $101.76
Upside: +21.86%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $328.02
Upside: +9.75%
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $147.03
Upside: +25.82%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $190.98
Upside: +41.38%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $11.91
Upside: -16.04%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $103.86
Upside: +160.93%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $15.18
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $18.34
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $84.74
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $17.77
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $96.28
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $5.90
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $74.14
Upside: +16.00%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.54
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $11.73
Upside: -